3 Most Promising Psychedelics for Mental Health Breakthroughs
Psychiatrist, researcher, and CEO of Zylorion Health, Dr. Peter Silverstone, ranks psychedelic medicines based on their potential to revolutionize mental health treatment.
psilocybin
Psychedelics Movement Marches Forward in These 4 US States
Another Michigan city decriminalizes psychedelic plants and fungi, while Maryland passes a bill to provide military veterans with cost-free access to healing medicines like ketamine, psilocybin, and MDMA.
New Study Links Psilocybin to Lower Risk of Opioid Addiction
Researchers attempt to replicate findings from a 2017 study that found classic psychedelic use conferred reduced risk of past-year opioid dependence and abuse.
Oregon Psilocybin Rules ‘May Have a Negative Impact on Lower Income Individuals’
The State acknowledges proposed psilocybin services rules will incur costs that “could ultimately be passed onto clients.”
5 Most Important Psychedelic Clinical Trials in 2022
Here’s why we think MAPS’ second Phase 3 MDMA trial is the most important psychedelic study of 2022, and 4 more that may have huge impacts.
Psychedelic Business Spotlight – March 25
This week in psychedelic business news: Filament Health scores 2nd psilocybin patent; a new psychedelics company emerges as one crumbles.
Psilocybin Is Effective in Reducing Weight Gain, New Study Shows
NeonMind finds that its proprietary psilocybin has the ability to target visceral fat, effectively reducing weight gain in obese subjects.
Another Psychedelics Company Is Crashing
Core One Labs appears to be following in footsteps of Mind Cure, but that doesn’t mean the entire psychedelics industry is in trouble.
Psychedelic Business Spotlight – March 18
This week in psychedelic business news: A psychedelics company folds; Ketamine Wellness Centers expand; Nova Mentis funds psilocybin studies.
Top 5 Most Influential Psychedelic Studies
We unpack five of the most important psychedelic studies conducted in recent years as psychedelics become mainstream medicine.
End of content
End of content